Dec 17, 2001
Genmab Appoints Rachel Gravesen, Formerly Of CNBC, as Vice President of Public Relations/Investor Relations

Dec 12, 2001
Genmab's HuMax-CD4 to Enter Phase III Studies In Arthritis

Nov 12, 2001
Genmab's HuMax-CD4 Shows Statistically Significant Dose Response In Psoriasis Phase II Study

Oct 29, 2001
Genmab To Present Initial Humax-CD4 Phase II Data At American College Of Rheumatology Conference

Oct 12, 2001
Genmab Announces Financial Results For The Nine Month Period Ending September 30, 2001

Oct 8, 2001
Genmab And Immunex In New Collaboration To Discover And Develop Cancer Antibody

Oct 3, 2001
Genmab Initiates Clinical Trials With Humax-IL15 - Second Genmab Product in Clinical Trials

Oct 1, 2001
Genmab's HuMax-IL15 Potent Against Inflammation

Jul 12, 2001
Genmab Announces Financial Results for the Half Year Ended 30 June 2001

Jun 19, 2001
Genmab and Medarex Announce Collaboration to Codevelop Anti-Inflamatory Antibody Therapeutic

Jun 13, 2001
Genmab’s HuMax-EGFr Eradicates Tumors in Mouse Cancer Studies

Jun 12, 2001
Genmab and deCODE Announce Major Alliance to Turn Population Genomics Discoveries into Human Antibody Therapeutics

Jun 12, 2001
Genmab and deCODE genetics Announce Pharmacogenomics Alliance in Rheumatoid Arthritis

May 7, 2001
Genmab and Roche to Collaborate on Human Antibodies

Apr 19, 2001
Genmab Announces First Quarter Results

Apr 5, 2001
Genmab Financial Calendar for 2001

Apr 2, 2001
Genmab, Medarex And Glaucus Announce Collaboration To Develop Human Antibody Therapeutics And Proteomics Technology

Mar 9, 2001
Genmab Announces Ordinary General Meeting on March 22nd

Mar 8, 2001
Genmab Announces Positive HuMax-CD4 Data

Mar 7, 2001
Genmab Announces Year-End Financial Results

Feb 16, 2001
Genmab's Date of Release of Annual Accounts 2000

Feb 13, 2001
Genmab Expands Clinical Development Capabilities

Jan 9, 2001
Genmab Initiates Second Phase II Study With HuMax-CD4